Functional analysis of carboxy-terminal peptide signaling of pro-amphiregulin and pro-epiregulin

双调蛋白原和上皮调节蛋白原羧基端肽信号传导的功能分析

基本信息

  • 批准号:
    20390082
  • 负责人:
  • 金额:
    $ 12.48万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 财政年份:
    2008
  • 资助国家:
    日本
  • 起止时间:
    2008 至 2010
  • 项目状态:
    已结题

项目摘要

Amphiregulin (AREG) and epiregulin (EREG), members of the EGF family, are synthesized as type I transmembrane protein precursors (proAREG and proEREG) and expressed on the cell surface. Shedding of proAREG and proEREG yield transmembrane-cytoplasmic fragments (AREGF-CTF and EREG-CTF), as well as soluble forms AREG and EREG. Here we demonstrated that the ectodomain shedding stimuli triggered endocytosis of both their CTFs and un-shed forms. They translocated from the plasma membrane to the nuclear membrane via retrograde membrane trafficking. Nuclear envelope localization of proAREG involves truncation of the C-terminus, which subsequently activates the ER-retrieval signal. The truncated form of proAREG interacts with A-type lamin and is retained at the inner nuclear membrane. Heterochromatin formation is then induced and global transcription is transiently suppressed. This study gives new insight into epigenetic chromatin organization in mammalian cells : a plasma-membrane-anchored growth factor is targeted to the inner nuclear membrane where it participates in dynamic chromatin organization and control of transcription.
双调蛋白(AREG)和表皮调节蛋白(EREG),EGF家族的成员,被合成为I型跨膜蛋白前体(proAREG和proEREG),并在细胞表面表达。proAREG和proEREG的脱落产生跨膜-胞质片段(AREGF-CTF和EREG-CTF),以及可溶形式AREG和EREG。在这里,我们证明了胞外域脱落刺激触发了它们的CTF和未脱落形式的内吞作用。它们通过逆行膜运输从质膜易位到核膜。proAREG的核膜定位涉及C-末端的截短,其随后激活ER-恢复信号。proAREG的截短形式与A型核纤层蛋白相互作用并保留在内核膜处。然后诱导异染色质形成,并短暂抑制整体转录。这项研究为哺乳动物细胞中的表观遗传染色质组织提供了新的见解:质膜锚定生长因子靶向于内核膜,在那里它参与动态染色质组织和转录控制。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
BCL6 degradation caused by the interaction with the C-terminus of pro-HB-EGF induces cyclin D2 expression in gastric cansers
与 pro-HB-EGF C 末端相互作用引起的 BCL6 降解诱导胃癌中细胞周期蛋白 D2 的表达
  • DOI:
  • 发表时间:
    2009
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Hirata Y;Ogasawara N;Sasaki M;Mizushima T;Shimura T;Mizoshita T;Mori Y;Kubota E;Wada T;Tanida S;Kataoka H;Kamiya T;Higashiyama S;Joh T
  • 通讯作者:
    Joh T
Promyelocytic leukemia zinc finger protein regulates interferon-mediated innate immunity.
  • DOI:
    10.1016/j.immuni.2009.04.013
  • 发表时间:
    2009-06-19
  • 期刊:
  • 影响因子:
    32.4
  • 作者:
    Xu D;Holko M;Sadler AJ;Scott B;Higashiyama S;Berkofsky-Fessler W;McConnell MJ;Pandolfi PP;Licht JD;Williams BR
  • 通讯作者:
    Williams BR
Region-specific proliferative response of neural progenitors to exogenous stimulation by growth factors following ischemia
  • DOI:
    10.1097/wnr.0b013e3282ff8641
  • 发表时间:
    2008-05-28
  • 期刊:
  • 影响因子:
    1.7
  • 作者:
    Oya, Soichi;Yoshikawa, Gakushi;Kawahara, Nobutaka
  • 通讯作者:
    Kawahara, Nobutaka
Novel monoclonal antibodies recognizing the active conformation of epidermal growth factor receptor
Lysophosphatidic acid stimulates epidermal growth factor-family ectodomain shedding and paracrine signaling from human lung fibroblasts.
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

HIGASHIYAMA Shigeki其他文献

HIGASHIYAMA Shigeki的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('HIGASHIYAMA Shigeki', 18)}}的其他基金

Regulation of ectodomian shedding by ADAM17 and remnant signaling
ADAM17 和残余信号传导对子宫外脱落的调节
  • 批准号:
    24390074
  • 财政年份:
    2012
  • 资助金额:
    $ 12.48万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Absolute Quantification of Transmembrane Protein Shedding and Its Application to the Monitoring of Chronic Inflammation
跨膜蛋白脱落的绝对定量及其在慢性炎症监测中的应用
  • 批准号:
    24659280
  • 财政年份:
    2012
  • 资助金额:
    $ 12.48万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Molecular mechanism of auto-translocation of membrane anchored EGFR ligand into the nuclear membrane and its diagnostic application of cancer
膜锚定EGFR配体自转入核膜的分子机制及其在癌症诊断中的应用
  • 批准号:
    22650228
  • 财政年份:
    2010
  • 资助金额:
    $ 12.48万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Carboxy-ternminal fragment signaling of membrane-anchored growth factors the EGF family
EGF家族膜锚定生长因子的羧基末端片段信号传导
  • 批准号:
    17390081
  • 财政年份:
    2005
  • 资助金额:
    $ 12.48万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Functional analysis of the C-treminal frangment of membrane-anchored growth factors
膜锚定生长因子C端片段的功能分析
  • 批准号:
    17014068
  • 财政年份:
    2005
  • 资助金额:
    $ 12.48万
  • 项目类别:
    Grant-in-Aid for Scientific Research on Priority Areas
C-terminal fragment signaling of membrane-anchored growth factor HB-EGF
膜锚定生长因子 HB-EGF 的 C 端片段信号传导
  • 批准号:
    15390097
  • 财政年份:
    2003
  • 资助金额:
    $ 12.48万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Physiological early response in tissue repair and regeneration -molecular mechanism of shedding : Analyses in wound healing model
组织修复和再生的生理早期反应-脱落的分子机制:伤口愈合模型分析
  • 批准号:
    13670139
  • 财政年份:
    2001
  • 资助金额:
    $ 12.48万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Membrane-anchored growth factor shedding in tissue regeneration and repaire
组织再生和修复中膜锚定生长因子的脱落
  • 批准号:
    11670141
  • 财政年份:
    1999
  • 资助金额:
    $ 12.48万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Characterization of a novel ligand for Receptor Tyrosine Kinase ErbB
受体酪氨酸激酶 ErbB 的新型配体的表征
  • 批准号:
    09680620
  • 财政年份:
    1997
  • 资助金额:
    $ 12.48万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似国自然基金

外泌体 Epiregulin 调控 PD-L1 促进口腔鳞癌免疫逃逸的作用及分子机制研究
  • 批准号:
    21ZR1453900
  • 批准年份:
    2021
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
超声靶向epiregulin载OPN-siRNA新型纳米诊疗体干预动脉支架术后再狭窄的实验研究
  • 批准号:
    81501483
  • 批准年份:
    2015
  • 资助金额:
    18.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Investigating the Role of Epiregulin During Human Intestinal Development
研究上皮调节蛋白在人类肠道发育过程中的作用
  • 批准号:
    10677386
  • 财政年份:
    2023
  • 资助金额:
    $ 12.48万
  • 项目类别:
Novel Antibody-Drug Conjugate Combination Therapy for Treating Colorectal Cancer
治疗结直肠癌的新型抗体-药物结合物联合疗法
  • 批准号:
    10435139
  • 财政年份:
    2022
  • 资助金额:
    $ 12.48万
  • 项目类别:
Novel Antibody-Drug Conjugate Combination Therapy for Treating Colorectal Cancer
治疗结直肠癌的新型抗体-药物结合物联合疗法
  • 批准号:
    10551243
  • 财政年份:
    2022
  • 资助金额:
    $ 12.48万
  • 项目类别:
脂肪性肝疾患を背景とした肝線維化過程への肝再生関連増殖因子の関与機構の解明
阐明肝再生相关生长因子参与脂肪肝肝纤维化过程的机制
  • 批准号:
    22K07954
  • 财政年份:
    2022
  • 资助金额:
    $ 12.48万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Understanding biased agonism in receptor tyrosine kinases to devise new modalities for their targeting in cancer
了解受体酪氨酸激酶的偏向激动作用,以设计其靶向癌症的新方式
  • 批准号:
    10324584
  • 财政年份:
    2021
  • 资助金额:
    $ 12.48万
  • 项目类别:
Epidermal Growth Factor Receptor Signaling in Fibrotic Skin Disease
纤维化皮肤病中的表皮生长因子受体信号传导
  • 批准号:
    10653037
  • 财政年份:
    2021
  • 资助金额:
    $ 12.48万
  • 项目类别:
Epidermal Growth Factor Receptor Signaling in Fibrotic Skin Disease
纤维化皮肤病中的表皮生长因子受体信号传导
  • 批准号:
    10214929
  • 财政年份:
    2021
  • 资助金额:
    $ 12.48万
  • 项目类别:
Epidermal Growth Factor Receptor Signaling in Fibrotic Skin Disease
纤维化皮肤病中的表皮生长因子受体信号传导
  • 批准号:
    10451658
  • 财政年份:
    2021
  • 资助金额:
    $ 12.48万
  • 项目类别:
Understanding how receptor tyrosine kinase activation dynamics specify proliferative cellular responses
了解受体酪氨酸激酶激活动力学如何指定增殖细胞反应
  • 批准号:
    10678825
  • 财政年份:
    2020
  • 资助金额:
    $ 12.48万
  • 项目类别:
Understanding how receptor tyrosine kinase activation dynamics specify proliferative cellular responses
了解受体酪氨酸激酶激活动力学如何指定增殖细胞反应
  • 批准号:
    10263909
  • 财政年份:
    2020
  • 资助金额:
    $ 12.48万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了